- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Congress Must Act for Cannabis Patients! Pass Medical Cannabis Legislation NOW! Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2021 State of the States Medical Cannabis in America Cannabis and Cannabis Resin- Critical Review Preparation Document Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- News News
- Join Join
IN THIS ISSUE
- New York Becomes 21st Medical Cannabis State
- Obama Administration Sets Stage for Policy Change
- NFL Commissioner Says League May Consider Medical Cannabis
- Florida Voters Will Decide Medical Cannabis Initiative
- Connecticut Announces Four Production Licensees
- Massachusetts Approves 20 Dispensaries, Invites 8 to Reapply
- Illinois Still Working on Rules, Invites Comment
- Pennsylvania Legislature Holds First Medical Cannabis Hearings
- Virginia Lobby Day Success
- Georgia Lawmaker Introduces CBD Bill
- ACTION ALERTS: Clemency Petition & Unity Conference
New York Becomes 21st Medical Cannabis State
In January, New York joined the 20 other states with medical cannabis programs, at least on a limited basis. Making use of a 1980 law, Gov. Andrew Cuomo has ordered the start of a pilot program to make medical cannabis available through 20 hospitals in the state.
"Research suggests that medical marijuana can help manage pain and treatment of cancer and other serious illnesses," Gov. Cuomo said in his annual State of State address. "We monitor the program to evaluate the effectiveness and the feasibility of a medical marijuana system."
Medical cannabis legislation has four times passed the New York Assembly on to be blocked by the state Senate. The law on which Gov. Cuomo has based his executive order is the Antonio G. Olivieri Controlled Substance Therapeutic Research Program, which was never implemented.
According to Assemblyman Richard Gottfried, a leading proponent of establishing a medical cannabis program in New York who was briefed on the governor’s plan, the state health department would set guidelines and choose the hospitals that will participate. Each hospital will establish a panel to decide, case-by-case, which patients will qualify to participate. No plan has been made for how the medical cannabis would be obtained for distribution.
Just last year Gov. Cuomo said of medical cannabis, "I do not support it at this time." With the addition of New York to the other 20 states and the District of Columbia, more than 45% of the US population now resides where medical cannabis is legally available.
Obama Administration Sets Stage for Policy Change
President Obama and Attorney General Eric Holder each made statements in January that set the stage for a change in federal policies on cannabis. AG Holder announced late last month that the Department of Justice will soon release new guidance for financial institutions that should allow medical cannabis providers and related businesses to utilize their services. Then in an interview The New Yorker, President Obama acknowledged that cannabis is no more dangerous than alcohol.
The President’s admission about the relative safety of cannabis flies in the face of the federal classification of cannabis as a Schedule I substance, defined as the most dangerous drugs with no medical use. When asked about that in a CNN interview on January 31, the President said it was up to Congress to change the classification of cannabis. In fact, while Congress placed cannabis in Schedule I in 1970, the Attorney General and the Drug Enforcement Administration, both of which operate at the direction of the White House, each have the regulatory authority to change its classification.
The Obama Administration may have an ally for changing federal law in Senate Majority Leader Harry Reid, who on January 16 told the Las Vegas Sun, “I think we need to take a real close look at this...I think that there’s some medical reasons for marijuana.” In the House, Representative Earl Blumenauer (D-OR), sponsor of HR 689, recently requested that the Administration take steps to remove cannabis from the Controlled Substances Act of 1970.
While the DOJ has yet to release its guidance on banking, allowing these businesses to utilize banks and other financial services will make it easier for state regulatory bodies to oversee them, just as with any other type of business. Whether the DOJ will also address the 280e tax issue that prevents cannabis businesses from taking normal business deductions on their tax filings is not clear.
ASA, as part of the Coalition for Rescheduling Cannabis (CRC), filed a petition in 2002 to reclassify marijuana for medical use. The Drug Enforcement Administration denied the petition in July 2011 and subsequently fought ASA's appeal to the D.C. Circuit.
NFL Commissioner Says League May Consider Medical Cannabis
In the wake of calls for the National Football League to allow its players to use medical cannabis to treat injuries, including a column in the Huffington Post by ASA Executive Director Steph Sherer, NFL Commissioner Roger Goodell said last month that the league will consider it.
"We will follow medicine, and if they determine this could be a proper usage in any context, we will consider that," Goodell said at a news conference. Goodell said if science showed it could be used to treat concussions -- which it has in preclinical studies – the NFL would consider it.
Currently all cannabis use is banned by NFL rules, whether for medical use or not. Two members of the Super Bowl-bound Seattle Seahawks defensive squad have been suspended for cannabis use this season.
At a press conference last week, Seahawks coach Pete Carroll endorsed the idea of lifting the ban on medical cannabis. "We have to explore and find ways to make our game a better game and take care of our players in whatever way possible,” he said. “Regardless of what other stigmas might be involved, we have to do this because the world of medicine is doing this."
In an editorial this week, the New York Times urged the NFL to take action, noting that “The league would merely be catching up to contemporary practice by creating a medical exception.”
The Times quotes the 1999 Institute of Medicine report on medical cannabis, which concluded that “cannabinoids can have a substantial analgesic effect.” Those on the field already recognize that, with several insiders estimating 50 to 60 percent of players use cannabis, primarily to manage pain.
Florida Voters Will Decide Medical Cannabis Initiative
Voters in Florida will decide a medical cannabis initiative this November, now that the Florida Supreme Court last month denied an attempt by the state Attorney General Pam Bondi to keep it off the ballot. Bondi and other Republican opponents had argued the ballot summary of the proposed constitutional amendment was misleading.
The "United for Care" campaign had already surpassed the 683,000 verified voter signatures necessary to qualify the measure.
Political analysts say Republicans are concerned that turnout in support of the medical cannabis measure could decide the outcome of a close race between Gov. Rick Scott (R), who opposes it, and his predecessor, former Gov. Charlie Crist, who is running as a Democrat and supports it.
A recent poll shows overwhelming public support for safe access. A November poll by Quinnipiac University found 82% favored “allowing adults to use marijuana for medical purposes if their doctor prescribes the drug.” Just 16% of voters said they opposed, and 70% of Republican voters said they support it. That shows increasing support since a campaign poll last January found 7 in 10 Florida voters support the measure.
To be enacted, a 60% supermajority of voters must vote yes. Proponents say they plan to spend $10 million in support of the measure.
Text of the initiative
States Moving Forward with Distribution Programs
Connecticut Announces Four Dispensary Licensees
Connecticut Gov. Dan Malloy announced last month that medical cannabis will go on sale there by this summer, now that officials have selected four production facility operators and locations. Joining him in the announcement were the state’s Consumer Protection Commissioner and Lt. Governor.
The four production facilities selected from 16 applicants are Advanced Grow Labs, LLC in West Haven, Connecticut Pharmaceutical Solutions, LLC in Portland and Theraplant, LLC in Watertown in addition to Curaleaf. Connecticut has registered approximately 1,700 patients under the law enacted in 2012. The four facilities were selected based on estimates of patient demand, production capacities and timetables and anticipated strain availability.
They must each put $2 million in escrow and pay a licensing fee to Department of Consumer Protection. Once licensed, they are required to open within 180 days. The state will announce dispensary licensees within the next two months.
Massachusetts Approves 20 Dispensaries, Invites 8 to Reapply
On January 30, the Massachusetts Department of Public Health (DPH) announced 20 out of about 100 applicants have been approved for medical cannabis dispensary licenses in the state. The approved dispensaries are spread between 10 counties, with the most being five in populous Middlesex County, which has more than 1.5 million residents. Boston, with a population of more than 700.000, will have two.
Four counties did not have a dispensary operator selected: Berkshire, Franklin, Dukes, and Nantucket, which have a combined population of more than 228,000. Eight of the rejected applications for counties where dispensaries have been approved were invited to resubmit new proposed locations within the counties without a selected dispensary.
"I've been impressed with the steps that DPH has taken to execute a transparent process and develop regulations that address concerns from an array of stakeholders," said Matthew J. Allen, Executive Director of the Massachusetts Patient Advocacy Alliance (MPAA).
ASA has been working with MPAA on the implementation of Massachusetts program. MPAA helped bring the medical marijuana ballot initiative to the voters, and has since been working to ensure that patients have a voice in implementation.
Delaware Accepting Dispensary Applications
State officials in Delaware have issued a call for applications to operate medical cannabis dispensaries in that state. Applications to become a provider are online at:
Illinois Still Working on Rules, Invites Comment
Medical cannabis officially became legal in Illinois on January 1, but state officials are still working on the rules for accessing it. Until those rules are in place, it remains illegal to possess or use medical cannabis. The Compassionate Use of Medical Cannabis Act, signed Aug. 1 by Gov. Pat Quinn, allows patients with one or more of 41 qualifying conditions to register with the program. Those registered will be allowed to obtain up to 2.5 ounces every 14 days from state-licensed dispensaries. The law allows for as many as 60 dispensaries, which will obtain the cannabis they distribute from 22 separately licensed cultivation centers.
State officials have proposed initial rules for qualifying patients, including requiring them to pay $150 a year to register, be fingerprinted for a background check and give up their right to own a firearm. The Illinois Department of Public Health, which will submit recommendations to a legislative panel in april, is accepting comment on the proposed rules until Friday, Feb. 7. Comments and suggested changes can be emailed to [email protected].
Once recommendations go to the Joint Commission on Administrative Rules, completing the public notice and comment process will take at least 90 days, meaning license applications for dispensaries and cultivation centers will not be available until fall.
Pennsylvania Legislature Holds First Medical Cannabis Hearings
A bipartisan bill that would establish a state medical cannabis program was in front of the Pennsylvania Senate Law & Justice Committee last month, the first time legislative hearings have been held on the issue.
Senate Bill 1182 is sponsored by senators from each end of the political spectrum, Daylin Leach, D-Montgomery, who first introduced legislation to allow medical cannabis in 2009, and Mike Folmer, R-Lebanon, one of the most conservative and influential Republicans.
Testifying at the hearing were representatives from the Pennsylvania State Nurses Association, which has endorsed the bill, and the Pennsylvania Medical Society. The proposal to allow doctors to recommend cannabis to their patients is favored by 96 percent of the state's medical community, according to a poll by the New England Journal of Medicine.
Republican Gov. Tom Corbett has previously said he would veto medical cannabis legislation.
Virginia Lobby Day Success
A grassroots lobby day at the Virginia General Assembly on Jan. 20 was successful in blocking HB 684, which would have repealed the state’s current but inactive medical cannabis law, and gave advocates a chance to explain why lawmakers should support the Virginia Medical Cannabis Act, draft legislation that would allow Virginia residents safe, legal access.
Virginia law requires patients to have a doctor’s prescription to legally possess and use medical cannabis, but doctors are prohibited from prescribing it because it is not a federally recognized medicine. The draft legislation would allow for access with a doctor’s recommendation, as other, workable state programs do.
Following a Saturday training on effective outreach, the lobby day included a productive meeting with Lt. Gov. Ralph Northam, MD, a pediatric neurologist who treated the child of a parent active in Safe Access Virginia, the state ASA chapter that organized the training and lobby day.
Georgia Lawmaker Introduces CBD Bill
A Republican state representative in Georgia last introduced a bill that would legalize a cannabis-based medicine for patients with severe seizure disorders.
Rep. Allen Peake has the support of the Medical Association of Georgia for a measure that would allow the distribution through five research hospitals of a cannabidiol (CBD) extract. CBD, one of the primary cannabinoids produced by the plant, has been shown to have many of the therapeutic properties of medical cannabis without the psychoactive effects associated with THC, though the two have been shown to work best in synergistic tandem.
In considering CBD-only legislation, the Georgia Legislature joins at least 10 others, including Alabama, Florida, Kentucky and Tennessee. Florida voters in November will decide a constitutional amendment to allow broader access to medical cannabis products.
Currently, 21 states and the District of Columbia allow medical cannabis use by qualified patients.
ACTION ALERTS—Unity Conference & Clemency Petition
The Obama Administration has asked which federal prisoners should be granted clemency. Sign ASA’s petition urging Pres. Obama to help Jerry Duval and other imprisoned medical cannabis patients at AmericansforSafeAccess.org/clemency.
ASA’s National Medical Cannabis Unity Conference, Navigating Medical Cannabis in the Mainstream, is your chance to gather with patients, providers, activists and medical and legal professionals to exchange ideas and learn best practices for the new political landscape. Then join us for a day of lobbying on Capitol Hill! Your citizen lobbying is six times more effective than special interest groups. Last year we had over 300 conference participants march on Washington for our lobby day, the largest in history for safe access. Early Bird Registration ends and scholarship applications open on Feb 15. Register today at AmericansForSafeAccess.org/unity2014.
PRINT THIS NEWSLETTER